Conference Coverage
Conference Coverage
Which infants with invasive bacterial infections are at risk for adverse outcomes?
TORONTO - Adverse outcomes are associated with prematurity, ill appearance, and bacterial meningitis.
Conference Coverage
ESBL-resistant bacteria spread in hospital despite strict contact precautions
Adherence to strict contact isolation and hand hygiene is never 100% in a real-life scenario.
Conference Coverage
CAZ-AVI appears safe, effective in pediatric complicated UTI, intra-abdominal infections
MADRID The combo CAZ-AVI, with or without metronidazole, cured close to 90% of UTIs and intra-abdominal infections in both studies.
Conference Coverage
Analysis finds inconsistent uptake of meningococcal B vaccines
TORONTO – Well-to-do teens were more likely than poorer ones to have received the meningococcal B vaccine in Philadelphia County, Pa.
Conference Coverage
Where the latest HCV drug combos fit in
MAUI, HAWAII – The biggest remaining challenge in the treatment of hepatitis C is to gain improved access to therapy, according to Steven L. Flamm...
Conference Coverage
Don’t shorten therapy for older, sicker cellulitis patients
Elderly patients with cellulitis and comorbid conditions probably need a full 12-day course of treatment.
Conference Coverage
Most HIV patients need treatment for acute HCV
Fewer than 12% of HIV infected men will clear new hepatitis C infections on their own and thus need DAA treatment.
Conference Coverage
New drugs provide new options in HCC
PHILADELPHIA – “We are on the cusp where new compounds not only are being tested, but they are being approved.”
Conference Coverage
Treatment of HCV in special populations
MAUI, HAWAII – Acute hepatitis C infection sometimes warrants treatment.
Conference Coverage
Hep B therapy: Indefinite or FINITE for e-negative patients?
LAS VEGAS –
Conference Coverage
Piperacillin-tazobactam tripled risk of death for patients with cephalosporin-resistant septicemia
The MERINO study was stopped after an interim analysis revealed increased mortality with use of piperacillin-tazobactam for septicemia.